Physician reimbursement for outpatient dialysis care: Past, present, and future

被引:5
作者
Anumudu, Samaya J. [1 ]
Erickson, Kevin F. [1 ,2 ,3 ]
机构
[1] Baylor Coll Med, Nephrol Sect, Houston, TX 77030 USA
[2] Baylor Coll Med, Ctr Innovat Qual Effectiveness & Safety, Houston, TX 77030 USA
[3] Rice Univ, Baker Inst Publ Policy, Houston, TX USA
关键词
economic incentives; end-stage renal disease; health policy; physician reimbursement; STAGE RENAL-DISEASE; NEPHROLOGIST VISITS; PATIENT OUTCOMES; HEMODIALYSIS; FREQUENCY; PAYMENT; READMISSIONS; FACILITIES; CONTACT; REFORM;
D O I
10.1111/sdi.12853
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Ever since Medicare began covering nearly every patient with end-stage renal disease in the United States, reimbursement for dialysis services has deviated from traditional fee-for-service. The method of reimbursing physicians for outpatient dialysis care has undergone a series of reforms in an effort to improve the overall quality of dialysis care and to control healthcare costs-changes that we are still seeing today. In 2004, the Centers for Medicare and Medicaid Services (CMS) changed the Monthly Capitation Payment (MCP) for physician reimbursement to the tiered fee-for-service system that is used today. This most recent reform encouraged more frequent face-to-face visits to patients receiving dialysis. While the quantity of visits increased in response to the change in reimbursement, the quality of care did not meaningfully improve, the policy may have had unintended negative health consequences and may have led to increases in wasteful physician and advanced practitioner effort. There are several promising opportunities to reform economic incentives around physician dialysis care that could improve the quality and value of care. These include new pay-for-performance initiatives, implementing incentives for high-quality care within fully capitated payment models, and reforming the MCP itself to link payment to high-value dialysis services.
引用
收藏
页码:68 / 74
页数:7
相关论文
共 43 条
[1]   Kidney transplantation as primary therapy for end-stage renal disease:: A National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQI™) conference [J].
Abecassis, Michael ;
Bartlett, Stephen T. ;
Collins, Allan J. ;
Davis, Connie L. ;
Delmonico, Francis L. ;
Friedewald, John J. ;
Hays, Rebecca ;
Howard, Andrew ;
Jones, Edward ;
Leichtman, Alan B. ;
Merion, Robert M. ;
Metzger, Robert A. ;
Pradel, Francoise ;
Schweitzer, Eugene J. ;
Velez, Ruben L. ;
Gaston, Robert S. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 (02) :471-480
[2]  
Alguire PatrickC., Understanding Capitation
[3]  
American Academy of Physician Assistants, 2010, SPEC PRACT PAS NEPHR
[4]  
[Anonymous], 2019, FR
[5]  
[Anonymous], END STAG REN DIS ESR
[6]   Future considerations for clinical dermatology in the setting of 21st century American policy reform: The Relative Value Scale Update Committee [J].
Barbieri, John S. ;
Nguyen, Harrison P. ;
Forman, Howard P. ;
Bolognia, Jean L. ;
Collins, Scott A. B. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (04) :816-820
[7]  
Centers for Medicare and Medicaid Services, COMPR ESRD CAR MOD C
[8]  
Centers for Medicare & Medicaid Services, 2017, FED REG DAILY J US G, V81, P80206
[9]  
Centers for Medicare & Medicaid Services, 2017, FED REG DAILY J US G, V82, P53016
[10]  
Centers for Medicare & Medicaid Services (CMS) HHS, 2003, Fed Regist, V68, P63195